呼吸器外科専門医が考えるMR検査の近未来展望: The future is at hand: MRI examinations of lung and thoracic disease
肺がんについて知りたい全ての方へ
日本語 English

References

References

  1. Usuda K, Iwai S, Yamagata A, Iijima1 Y, Motono N, Matoba M, Doai M, Hirata K, Uramoto H. Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses. Cancers 2021; 13(15): 3713, doi: 10.3390/cancers13153713
  2. Usuda K, Iwai S, Yamagata A, Iijima1 Y, Motono N, Matoba M, Doai M, Hirata K, Uramoto H. Whole-lesion Apparent Diffusion Coefficient Histogram analysis: Significance for Discriminating Lung Cancer from Pulmonary Abscess and Mycobacterial Infection. Cancers 2021; 13(11): 2720. https://doi.org/10.3390/cancers13112720
  3. Usuda K, Iwai S, Yamagata A, Iijima1 Y, Motono N, Matoba M, Doai M, Hirata K, Uramoto H. How to Discriminate Lung Cancer from Benign Pulmonary Nodules and Masses? Usefulness of Diffusion-Weighted Magnetic Resonance Imaging with ADC and Inside/Wall ADC Ratio. Clinical Medicine Insights: Oncology 2021; 15: 1-9. https://doi.org/10.1177/11795549211014863
  4. Usuda K, Ishikawa M, Iwai S, Iijima1 Y, Motono N, Matoba M, Doai M, Hirata K, Uramoto H. Combination Assessment of Diffusion-Weighted Imaging and T2-Weighted Imaging Is Acceptable for the Differential Diagnosis of Lung Cancer from Benign Pulmonary Nodules and Masses. Cancers 2021; 13: 1551. https://doi.org/10.3390/cancers13071551
  5. Usuda K, Iwai S, Yamagata A, Iijima1 Y, Motono N, Matoba M, Doai M, Yamada S, Ueda Y, Hirata K, Uramoto H. Diffusion‐weighted whole‐body imaging with background suppression (DWIBS) is effective and economical for detection of metastasis or recurrence of lung cancer. Thoracic cancer 2021:12 (5):676 – 684. doi:10.1111/1759-7714.13820.
  6. Usuda K, Iwai S, Yamagata A, Iijima1 Y, Motono N, Matoba M, Doai M, Yamada S, Ueda Y, Hirata K, Uramoto H.  Differentiation between suture recurrence and suture granuloma after pulmonary resection for lung cancer by diffusion-weighted magnetic resonance imaging or FDG-PET / CT. Transl Oncol.2021;14(2):100992. doi: 10.1016/j.tranon.2020.100992.
  7. Usuda K, Iwai S, Yamagata A, Sekimura A, Motono N, Matoba M, Doai M, Yamada S, Ueda Y, Hirata K, Uramoto H. Relationships and Qualitative Evaluation Between Diffusion-Weighted Imaging and Pathologic Findings of Resected Lung Cancers.Cancers 2020 ;12(5):1194. doi: 10.3390/cancers12051194.
  8. Usuda K, Iwai S, Funasaki A, Sekimura A, Motono N, Matoba M, Doai M, Yamada S, Ueda Y, Uramoto H. Diffusion-Weighted Imaging Can Differentiate between Malignant and Benign Pleural Diseases. Cancers 2019;11(6):811. doi: 10.3390/cancers11060811.
  9. Usuda K, Iwai S, Funasaki A, Sekimura A, Motono N, Matoba M, Doai M, Yamada S, Ueda Y, Uramoto H. Diffusion-weighted magnetic resonance imaging is useful for the response evaluation of chemotherapy and/or radiotherapy to recurrent lesions of lung cancer. Transl Oncol. 2019;12(5):699-704. doi: 10.1016/j.tranon.2019.02.005. 
  10. Usuda K, Funasaki A, Sekimura A, Motono N, Matoba M, Doai M, Yamada S, Ueda Y, Uramoto H. FDG-PET/CT and diffusion-weighted imaging for resected lung cancer: correlation of maximum standardized uptake value and apparent diffusion coefficient value with prognostic factors. Med Oncol. 2018;35(5):66. doi: 10.1007/s12032-018-1128-1.
  11. Usuda K, Funazaki K, Maeda R, Sekimura A, Motono N. Matoba , Uramoto H. Economic Benefits and Diagnostic Quality of Diffusion-weighted Magnetic Resonance Imaging for Primary Lung cancer. Ann Thoracic Cardiovasc Surgery 2017; 23 (6): 275-280. doi: 10.5761/atcs.ra.17-00097
  12. Tsuchiya N, Doai M, Usuda K, Uramoto H, Tonami H. Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion. PloS One. 2017;12(2):e0172433. doi: 10.1371/journal.pone.0172433. eCollection 2017.
  13. Usuda K, Sagawa M, Maeda S, Motono N, Tanaka M, Machida Y, Matoba TM, Watanabe N, Tonami H, Ueda Y, Uramoto H. Diagnostic Performance of Whole-Body Diffusion-Weighted Imaging Compared to PET-CT Plus Brain MRI in Staging Clinically Resectable Lung Cancer. Asian Pac J Cancer Prev. 2016;17:2775-2780. https://pubmed.ncbi.nlm.nih.gov/27356689/
  14. Usuda K,Maeda S, Motono NUeno MTanaka MMachida YMatoba M, Watanabe N,, Tonami HUeda YSagawa M, Diffusion Weighted Imaging Can Distinguish Benign from Malignant Mediastinal Tumors and Mass Lesions. Comparison with Positron Emission Tomography. Asian Pac. J. Cancer Prev. 2015; 16: 6469-6475. doi: 10.7314/apjcp.2015.16.15.6469.
  15. Usuda K, Maeda S, Motono N, Ueno M, Tanaka M, Machida Y, Matoba M,Watanabe N, Tonami H, Ueda Y, Sagawa M. Diagnostic Performance of Diffusion Weighted Imaging for Multiple Hilar and Mediastinal Lymph Nodes with FDG Accumulation.  Asian Pac. J. Cancer Prev. 2015; 16 : 6401-6406. doi: 10.7314/apjcp.2015.16.15.6401.
  16. Usuda K,Sagawa MMotono NUeno MTanaka MMachida YMaeda SMatoba MKuginuki YTaniguchi MTonami HUeda YSakuma T. Recurrence and metastasis of lung cancer demonstrate decreased diffusion on diffusion-weighted magnetic resonance imaging. Asian Pac J Cancer Prev. 2014; 15 (16); 6843-6848. doi: 10.7314/apjcp.2014.15.16.6843.
  17. Usuda K,Sagawa MMotono NUeno MTanaka MMachida YMaeda SMatoba MKuginuki YTaniguchi MTonami HUeda YSakuma T. Diagnostic performance of diffusion weighted imaging of malignant and benign pulmonary nodules and masses: comparison with positron emission tomography. Asian Pac J Cancer Prev. 2014; 15 (11):4629-4635. doi: 10.7314/apjcp.2014.15.11.4629.
  18. Usuda K, Sagawa M, Motono N, Ueno M Tanaka M, Machida Y, Matoba M, Kuginuki Y, Taniguchi M, Ueda Y, Sakuma T. Advantages of diffusion-weighted imaging over positron emission tomography-computed tomography in assessment of hilar and mediastinal lymph node in lung cancer. Ann Surg Oncol 2013; 20 (5);1676-1683. doi: 10.1245/s10434-012-2799-z.
  19. Usuda K, Zhao XT, Sagawa M, Aikawa H, Ueno M, Tanaka M, Machida Y, Matoba M, Ueda Y, Sakuma T. Diffusion-weighted imaging (DWI) signal intensity and distribution represent the amount of cancer cells and their distribution in primary lung cancer. Clinical Imaging 2013; 37 (2); 265-272. doi: 10.1016/j.clinimag.2012.04.026. 
  20. Usuda K, Zhao XT, Sagawa M, Matoba M, Kuginuki Y, Ueda Y, Sakuma T. Diffusion-weighted imaging is superior to PET in the detection and nodal assessment of lung cancers. Ann. Thorac. Surg. 2011; 91(6): 1689-1695. doi: 10.1016/j.athoracsur.2011.02.037.
  21. 薄田勝男, 松井琢真, 本野 望, 町田雄一郎, 的場宗孝, 利波久雄, 上田善道, 浦本秀隆.胸部腫瘍に対するMR拡散強調画像の有用性とその展望. 日呼吸誌 6: 305-311, 2017.
  22. 薄田 勝男,松井 琢真,本野  望,的場 宗孝,湊  宏,浦本 秀隆. MR拡散強調画像が術前肺門・縦隔リンパ節転移の評価に有益であった肺癌の2症例 日呼吸誌, 7(1): 68-73, 2018.
ABOUT ME
薄田 勝男
呼吸器外科専門医として長年肺癌診療に携わってまいりました。 このサイトでは肺がん診断におけるMRIの有効性をご紹介しております。

コメントを残す